Xiaoping Chen
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Job Satisfaction and Organizational Behavior
Papers in
-
- RNA modifications and cancer 8
- Epigenetics and DNA Methylation 5
-
- Antiplatelet Therapy and Cardiovascular Diseases 14
- Co-authors
- Chun Hui (1 shared paper)Douglas J. Sego (1 shared paper)Wei Zhang (23 shared papers)Hong‐Hao Zhou (19 shared papers)Zhaoqian Liu (18 shared papers)Hong‐Hao Zhou (11 shared papers)Mu-Peng Li (18 shared papers)Hong‐Hao Zhou (9 shared papers)
- Journals
- Scientific Reports (5 papers)PLoS ONE (5 papers)Frontiers in Cardiovascular Medicine (4 papers)European Journal of Clinical Pharmacology (4 papers)Frontiers in Pharmacology (4 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Xiaoping Chen
188 papers receiving 4.1k citations
Peers
Comparison fields: 5 of 181
- Cancer Research 509
- Organizational Behavior and Human Resource Management 327
- Pharmacology 239
- Cardiology and Cardiovascular Medicine 405
- Infectious Diseases 309
Countries citing papers authored by Xiaoping Chen
This map shows the geographic impact of Xiaoping Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoping Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoping Chen more than expected).
Fields of papers citing papers by Xiaoping Chen
This network shows the impact of papers produced by Xiaoping Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoping Chen. The network helps show where Xiaoping Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaoping Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 194 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1998 | 383 | |
| 2 | 2020 | 314 | |
| 3 | 2004 | 196 | |
| 4 | 2011 | 157 | |
| 5 | 2017 | 152 | |
| 6 | 2010 | 117 | |
| 7 | 2022 | 78 | |
| 8 | 2017 | 78 | |
| 9 | 2017 | 77 | |
| 10 | 2014 | 76 | |
| 11 | 2016 | 69 | |
| 12 | 2019 | 65 | |
| 13 | 2016 | 54 | |
| 14 | 2010 | 54 | |
| 15 | 2019 | 52 | |
| 16 | 2013 | 52 | |
| 17 | 2015 | 46 | |
| 18 | 2010 | 46 | |
| 19 | 2012 | 46 | |
| 20 | 2010 | 45 |
About Xiaoping Chen
Xiaoping Chen is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine, Epidemiology, Cancer Research and Physiology, having authored 194 papers that have together received 4.2k indexed citations. Recurring topics across this work include Antiplatelet Therapy and Cardiovascular Diseases (14 papers), Cancer-related molecular mechanisms research (9 papers), RNA modifications and cancer (8 papers), Hepatitis B Virus Studies (7 papers), Liver Disease Diagnosis and Treatment (6 papers), Platelet Disorders and Treatments (5 papers), Hepatitis C virus research (5 papers) and Epigenetics and DNA Methylation (5 papers). The work is most often cited by research in Cancer Research (509 citations), Organizational Behavior and Human Resource Management (327 citations), Pharmacology (239 citations), Cardiology and Cardiovascular Medicine (405 citations) and Infectious Diseases (309 citations). Xiaoping Chen has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Chun Hui, Douglas J. Sego, Wei Zhang, Hong‐Hao Zhou, Zhaoqian Liu, Hong‐Hao Zhou, Mu-Peng Li, Hong‐Hao Zhou, Yuan‐Jian Li and Jie Tang. Their work appears in journals such as Scientific Reports, PLoS ONE, Frontiers in Cardiovascular Medicine, European Journal of Clinical Pharmacology and Frontiers in Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.